Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citra Tubindo Tbk. (CTBN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Citra Tubindo Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Citra Tubindo Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Citra Tubindo Tbk. trades at Rp4,000 (market cap 3.19T, 3.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Citra Tubindo Tbk. is far larger — about 5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 3.9K). Which is the better fit depends on your goals.

CTBNLABS
Market Cap
3.19T635.95B
Volume
3.9K843K
Lot
398.43K
Turnover
15.59M137.6M
Average Price
3,996.92163.22
Value
15.59M137.6M
Indicative Equilibrium Price
4,000165
Indicative Equilibrium Volume
4246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTBN
View details
LABS
View details

About Citra Tubindo Tbk.

PT Citra Tubindo Tbk (the Company) was established on August 23rd, 1983, on Batam Island under the rules of the Domestic Capital Investment (PMDN) the main activities of the Company are seamless pipe processing, end finishing of Oil Country Tubular Goods (OCTG) and fabricating accessories for the Oil and Gas Industry. The Threading and End Finishing plant commenced commercial operation in 1984 and received American Petroleum Institute (API) in the same year. In 1986 the Company installed and put into operation a precision electro-plating plant which also passed the stringent requirements of MEPSI (Mobil Exploration and Production Services Inc.) standards. The Company has also built an assembly line for Drilltec Protectors, to reduce the dependency on overseas supplies. The products of the Company are distributed among domestic and international oil and gas contractors operating in Indonesia, and increasingly exported to contractors working in countries such as Malaysia, India, Vietnam, the Middle East, Japan Canada, Australia, Venezuela and the Philippines.

Read more on CTBN

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS